U.S. Renewable Energy Stock News

Camtek (NasdaqGM:CAMT) sets the tone with Q1 2026 earnings Camtek (NasdaqGM:CAMT) opened 2026 with Q1 revenue of US$121.7 million and basic EPS of US$0.68, setting a clear marker for how the year is starting to shape up. The company has seen revenue move from US$117.3 million in Q4 2024 to US$128.1 million in Q4 2025, with basic EPS across those periods ranging from US$0.73 to US$0.78, while trailing 12 month EPS sits at US$1.05 on revenue of US$499.1 million. With a trailing net margin of...

Paysign, Inc. reported past first-quarter 2026 results on May 12, posting revenue of US$28.04 million and net income of US$5.44 million, with diluted EPS of US$0.09 from continuing operations. The quarter marked a shift as patient affordability programs became Paysign’s largest revenue contributor, reflecting a mix change toward higher-margin pharma offerings. We’ll now examine how this record first quarter and the rise of patient affordability as Paysign’s largest revenue stream affect its...

Q1 earnings and guidance put Solstice Advanced Materials (SOLS) in focus Solstice Advanced Materials (SOLS) has come into focus after reporting first quarter 2026 earnings showing revenue of US$991 million and net income of US$85 million, alongside fresh second quarter and full year net sales guidance. See our latest analysis for Solstice Advanced Materials. At a share price of US$86.81, Solstice Advanced Materials has seen a 7 day share price return of 11.64% and a year to date share price...

Soluna Holdings, Inc. recently closed its April 29, 2026 shelf registration, raising US$2.66 million through the offering of 2,459,400 shares of common stock. This completed shelf registration, alongside ongoing SEC filings, highlights the company’s continued effort to secure funding for its cryptocurrency mining and data center activities. Next, we’ll consider how Soluna’s recent capital raise via this shelf registration closing shapes the company’s broader investment narrative. Uncover the...

Arteris (AIP) has opened Q1 2026 with revenue of US$22.9 million and a basic EPS loss of US$0.17, setting the tone for another growth focused but loss making quarter. The company has seen quarterly revenue move from US$16.5 million in Q1 2025 to US$22.9 million in Q1 2026, while basic EPS losses have ranged between US$0.21 and US$0.17 over the same period, which keeps the spotlight firmly on how efficiently that top line is being converted. With revenue expansion set against ongoing losses,...

Valens Semiconductor recently reported past first-quarter 2026 results, with revenues of US$16.86 million, a net loss of US$8.29 million, and GAAP gross margin of 62.2%, while reiterating full-year revenue guidance of US$75 million to US$77 million. Management highlighted stronger-than-expected demand for its VS3000 and VS6320 chipsets and signaled a more confident outlook for second-half 2026 growth across audio-video and automotive connectivity markets. We’ll now examine how beating Q1...

Q1 2026 earnings snapshot Zebra Technologies (ZBRA) has opened Q1 2026 with revenue of US$1.5b and basic EPS of US$2.75, setting a clear marker for how the year is starting to shape up. The company has seen quarterly revenue move from US$1.31b in Q1 2025 to US$1.50b in Q1 2026, while basic EPS over the same quarters went from US$2.65 to US$2.75. This gives investors a clear view of how the top and bottom lines are tracking year on year. With trailing 12 month net profit margins sitting below...

Even if it's not a huge purchase, we think it was good to see that Matthew Miller, the Co-Chairman of the Board of...

Doximity (NYSE:DOCS) has partnered with Aledade to plug its HIPAA-compliant Clinical AI Suite, including Scribe and Ask, into Aledade’s EHR overlay platform. The integration targets value-based primary care and independent practices, aiming to streamline documentation and surface clinical insights at the point of care. Doximity has also begun monetizing its AI-driven search product for pharmaceutical marketers, opening a new revenue channel tied to digital promotion budgets. Doximity,...

The analysts covering Editas Medicine, Inc. ( NASDAQ:EDIT ) delivered a dose of negativity to shareholders today, by...

With WaFd on many watchlists, the key question is whether the recent share price reflects a fair deal or if there is still value on the table. At a last close of US$34.59, the stock is down 2.9% over the past week, up 5.7% over the past month, and has returned 21.2% over the past year, which can change how investors think about both upside potential and risk. Recent coverage has focused on WaFd's position in the US regional banking space and how investors are reacting to sector specific...

Why recent LiDAR partnerships matter for Innoviz Technologies (NasdaqCM:INVZ) Recent announcements around InnovizTwo evaluations set the stage for Innoviz Technologies (NasdaqCM:INVZ), including an on-sensor perception software agreement and a separate letter of intent with LOXO for L4 autonomous delivery vehicles. See our latest analysis for Innoviz Technologies. These new LiDAR evaluation agreements come as momentum has picked up in the short term, with 1 day, 7 day and 30 day share price...

It looks like Papa John's International, Inc. ( NASDAQ:PZZA ) is about to go ex-dividend in the next three days. The...

Coherent Corp.'s ( NYSE:COHR ) stock was strong after they recently reported robust earnings. We did some analysis and...

Amtech Systems, Inc. ( NASDAQ:ASYS ) announced a healthy earnings result recently, and the market rewarded it with a...

Caris Life Sciences (CAI) is drawing fresh attention after publishing new tumor mutational burden data, rolling out MI Clarity for breast cancer, securing MolDX approval for ChromoSeq, and reporting detailed first quarter 2026 results. See our latest analysis for Caris Life Sciences. The latest run of product launches and clinical data has not yet translated into positive share price momentum, with Caris Life Sciences' share price return falling 12.35% over the past day and 45.55% year to...

In the first quarter of 2026, One Stop Systems, Inc. reported revenue of US$8.07 million, up from US$5.21 million a year earlier, with its net loss narrowing to US$0.52 million from US$2.02 million, and management also confirmed it is actively seeking acquisitions supported by a strengthened balance sheet. An interesting aspect of this update is the combination of sharply improved quarterly results, stronger bookings and management’s intention to deploy capital into selective acquisitions to...

MasTec (NYSE:MTZ) held an in-depth Investor Day, outlining multi-year targets for its business. Management detailed how the company is positioned to serve power delivery, clean energy, and data center infrastructure demand. The event included a raised multi-year outlook and granular discussion of grid modernization and data center related projects. For investors watching NYSE:MTZ, the Investor Day comes after a significant rise in the stock, with shares up 86.2% year to date and 169.4% over...

In the last week, the United States market has stayed flat, yet it has seen a remarkable 25% increase over the past year with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for continued success.

The United States market has seen a flat performance over the last week but has experienced a notable 25% increase over the past year, with earnings projected to grow by 17% annually. In this dynamic environment, identifying undiscovered gems often involves finding stocks that offer unique growth potential and align with these promising earnings forecasts.

In the last week, the United States market has stayed flat, yet it is up 25% over the past year with earnings forecast to grow by 17% annually. In such a dynamic environment, identifying leading dividend stocks that offer both stability and attractive yields can be a strategic approach for investors seeking income and potential growth.

Recent interest in NVE (NVEC) has picked up after Semitech was appointed an authorized distributor for the company’s isolation products. The move is aimed at widening access to its digital isolation solutions in the U.S. See our latest analysis for NVE. NVE’s recent distributor agreement with Semitech and the latest full year results, which showed revenue of US$26.33 million and net income of US$15.2 million, have coincided with strong momentum. This includes a 30 day share price return of...

Omeros Corporation reported past first-quarter 2026 results showing sales of US$9.89 million and a shift from a net loss to net income of US$56.06 million, with both basic and diluted earnings per share turning positive versus the prior year. Beyond the headline profit swing, the quarter reflects earnings power influenced by noncash items and comes alongside ongoing regulatory and clinical momentum for YARTEMLEA and the broader complement pipeline. We’ll now examine how this sharp earnings...

Venture Global (VG) opened Q1 2026 with revenue of US$4.6 billion and basic EPS of US$0.22, setting the tone for how investors will read the latest move in both the top and bottom line. Over the past year, the company has seen quarterly revenue move from US$2,894 million in Q1 2025 to US$4,599 million in Q1 2026, while basic EPS shifted from US$0.17 to US$0.22 across the same periods, giving a clear sense of how sales and per share profitability are tracking into the new fiscal year. With...